Project description
Personalised device to improve treatment of chronic respiratory diseases
Chronic respiratory diseases affect around a billion people worldwide, are not curable, and require lifelong treatment to control symptoms and sustain the quality of life of those affected. The EU-funded A3BL project is developing a smart breathing device that combines an ergonomically designed mouthpiece and adjustable resistance regulators. A mobile application will enable personalised treatments and remote access for medical providers. The goal is to provide a reliable and safe solution that increases compliance with the treatment plans. During Phase I of the project, the regulatory strategy and the product will be validated and improved based on feedback from potential end users.
Objective
There are about 1 billion persons with chronic respiratory conditions, such as asthma and chronic obstructive pulmonary disease, of which about 4 million die prematurely each year. These respiratory diseases represent a heavy socio-economic burden to the healthcare system. Just in Europe, the healthcare and lost production costs amount to €82 billion/year. Nevertheless, the existing approaches for exercise-based pulmonary rehabilitation of these patients are expensive, inefficient or slow, and often lack a connected system for a continuous monitoring, leading to poor compliance of patients that often quit treatment.
Airofit A/S is bringing to market Airofit – a connected device for the respiratory training of lung muscles, conceived to promote the strengthening of breathing musculature of patients suffering with respiratory problems. Airofit offers several disruptive features, including 1) connection to a smartphone app and Expert module (game changer features) for a real-time, remote but tight monitoring of patients’ progress by its doctors, 2) controllable inhaling and exhaling resistances in a 3) portable and user-friendly technology, and a 4) cost-efficient solution with the lowest market price comparatively to similar solutions for the same market segment.
To bridge the remaining steps towards full scale commercialization of Airofit, the company must clinically validate Airofit and make it compliant with medical devices regulatory standards, while consolidating our strategic partnering throughout the medical devices value chain to ensure public acceptance and enough muscle for Airofit production ramp-up. The to-market maturation of Airofit within the present innovation project represents a strategic opportunity yielding a very large business opportunity, opening a potential revenue stream summing up to €209M over the 5-years post market introduction, from which our SME stands to capture over €109M as gross profits, while creating 48 new full-time positions.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences computer and information sciences software
- medical and health sciences clinical medicine pneumology asthma
- medical and health sciences clinical medicine physiotherapy
- medical and health sciences health sciences infectious diseases RNA viruses coronaviruses
- engineering and technology electrical engineering, electronic engineering, information engineering information engineering telecommunications mobile phones
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
2200 KOBENHAVN
Denmark
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.